Stocks / NASDAQ / ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc.

Our Opinion

ProMIS Neurosciences Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that they use animals for drug testing.

Among the validated product candidates, we use two complementary sets of assays to identify those that demonstrate evidence for blocking of neurotoxicity (killing of neurons) and inhibition of propagation (spreading throughout the brain). Only validated products that meet these criteria can move on to undergo testing in animal models to confirm their therapeutic potential. Read the following article

Company Description

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Company Website: